Recent Company News

• 08:15 AM ET Nov 04, 2025
  

  BrainsWay reports NIH grant to U.S. research team investigating accelerated Deep TMS for treatment of alcohol use disorder ($17.38, 0.00)

• 10:06 AM ET Nov 03, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (194 total)

• 09:57 AM ET Oct 28, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (131 total)

• 10:02 AM ET Oct 27, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (168 total)

• 07:33 AM ET Oct 27, 2025
  

  Brainsway announces additional minority-stake investments in U.S. mental health providers ($16.83, 0.00)

• 04:59 PM ET Sep 16, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:18 AM ET Sep 16, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:42 AM ET Sep 16, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:34 AM ET Sep 16, 2025
  

  Brainsway issues press release on receipt of FDA Clearance for Accelerated Deep TMS Protocol for non-invasive treatment of Major Depressive Disorder (MDD) ($15.10, 0.00)

• 03:02 PM ET Sep 15, 2025
  

  FDA grants new clearance for BrainsWay Deep TMS System ($15.10, -0.67)